Clinical Features and Therapeutic Implications of 104 Episodes of Monomicrobial Aeromonas Bacteraemia
Authors:
- H.-C LeeHLH.-C Lee
- Y.-C ChuangYCY.-C Chuang
- C.-C LiuCLC.-C Liu
- J.-J WuJWJ.-J Wu
- 1 May 2000
- journal article
- research article
- Published by Elsevier in Journal of Infection
- Vol. 40 (3) , 267-273
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Distribution and expression of beta-lactamase genes among Aeromonas sppJournal of Antimicrobial Chemotherapy, 1997
- Bacteremia Due to Stenotrophomonas (Xanthomonas) maltophilia: A Prospective, Multicenter Study of 91 EpisodesClinical Infectious Diseases, 1996
- Aeromonas bacteraemia in burn patientsBurns, 1996
- Aeromonas septicaemia in Hong Kong species distribution and associated diseaseJournal of Infection, 1995
- Aeromonas Bacteremia: Review of 59 EpisodesClinical Infectious Diseases, 1995
- A clinical isolate of Aeromonas sobria with three chromosomally mediated inducible β-lactamases: a cephalosporinase, a penicillinase and a third enzyme, displaying carbapenemase activityJournal of Antimicrobial Chemotherapy, 1995
- Musculoskeletal and Soft Tissue Aeromonas Infection: An Environmental DiseaseMayo Clinic Proceedings, 1992
- In vitro susceptibility ofAeromonas caviae, Aeromonas hydrophila andAeromonas sobria to fifteen antibacterial agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Aeromonas septicemia: Relationship of species and clinical featuresPathology, 1989
- Selection of enhanced cefotaxime resistance in Enterobacter spp.Journal of Antimicrobial Chemotherapy, 1987